Moberg Pharma AB (publ)
STO:MOB

Watchlist Manager
Moberg Pharma AB (publ) Logo
Moberg Pharma AB (publ)
STO:MOB
Watchlist
Price: 7.87 SEK -0.63% Market Closed
Market Cap: 376.8m SEK

Wall Street
Price Targets

MOB Price Targets Summary
Moberg Pharma AB (publ)

Wall Street analysts forecast MOB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MOB is 11.22 SEK with a low forecast of 11.11 SEK and a high forecast of 11.55 SEK.

Lowest
Price Target
11.11 SEK
41% Upside
Average
Price Target
11.22 SEK
43% Upside
Highest
Price Target
11.55 SEK
47% Upside
Moberg Pharma AB (publ) Competitors:
Price Targets
AJANTPHARM
Ajanta Pharma Ltd
13% Upside
000100
Yuhan Corp
25% Upside
600085
Beijing Tongrentang Co Ltd
32% Upside
KILITCH
Kilitch Drugs (India) Ltd
39% Upside
SBBC
Simply Better Brands Corp
80% Upside
MEDCL
Medincell SA
50% Upside

Revenue
Forecast

Revenue Estimate
Moberg Pharma AB (publ)

The compound annual growth rate of Moberg Pharma AB (publ)'s revenue for the next 3 years is 138%.

N/A
Past Growth
138%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Moberg Pharma AB (publ)

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Moberg Pharma AB (publ)

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MOB's stock price target?
Price Target
11.22 SEK

According to Wall Street analysts, the average 1-year price target for MOB is 11.22 SEK with a low forecast of 11.11 SEK and a high forecast of 11.55 SEK.

What is Moberg Pharma AB (publ)'s Revenue forecast?
Projected CAGR
138%

The compound annual growth rate of Moberg Pharma AB (publ)'s revenue for the next 3 years is 138%.

Back to Top